Skip to content
Home » Kasumigaseki Capital Co., Ltd. Saitama City, Saitama Prefecture Notice regarding the sale of real estate for sale (land for healthcare facility development)

Kasumigaseki Capital Co., Ltd. Saitama City, Saitama Prefecture Notice regarding the sale of real estate for sale (land for healthcare facility development)

Kasumigaseki Capital Co., Ltd.
[Saitama City, Saitama Prefecture] Notice regarding the sale of real estate for sale (health care facility development site)
……
Kasumigaseki Capital Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; Representative Director: Koshiro Kawamoto; hereinafter referred to as the “Company”) has provided Tokyo Tatemono Co., Ltd. (Headquarters: Tokyo; We would like to inform you that we have concluded a contract to sell the property to Chuo Ward, Representative Director and President Executive Officer: Hitoshi Nomura (hereinafter referred to as “Tokyo Tatemono”) as follows.
In addition, our consolidated subsidiary KC-Welfare Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, Representative Director: Yoshihisa Furukawa) will be entrusted by Tokyo Tatemono with project management duties during the development period of this project, and will work in collaboration with our company. We will proceed with the development of this healthcare facility.
1. Property overview
[Image 1: https://prtimes.jp/i/48076/217/resize/d48076-217-6fdf0983f826d341836a-0.png&s3=48076-217-0124334e2bf315cf9ac2f514d3d65647-3081×438.png ]
2. Sold to
[Table 2: https://prtimes.jp/data/corp/48076/table/217_1_f9d34dd68160633c12ad78e0c0396e5a.jpg ]
3. schedule
Sales contract conclusion date: June 5, 2024
Expected purchase and settlement date: July 31, 2024
Four. transaction price
Regarding the transaction price, we will refrain from making it public due to the confidentiality agreement between our company and our business partners.
Five. Future outlook
The sales of the above development land have already been factored into the consolidated financial forecast for the fiscal year ending August 2024. Sales will be recorded when the performance obligation is satisfied (sales settlement).
■List of healthcare facility development plans
[Image 2: https://prtimes.jp/i/48076/217/resize/d48076-217-541caab6c48c413e0e74-4.png&s3=48076-217-ad6d8e148361a2e24d03ffdfe5fa164c-2552×1473.png ]
■List of healthcare facilities in operation
[Image 3: https://prtimes.jp/i/48076/217/resize/d48076-217-e8dd34549993c411e137-2.png&s3=48076-217-22b06f4a62108e8df68c79c8edc7cc90-2535×529.png ]
Company Profile
Company name: Kasumigaseki Capital Co., Ltd. Established: September 2011 Representative: Koshiro Kawamoto, Representative Director Head Office: 22nd Floor, West Building, Kasumigaseki Common Gate, 3-2-1 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013 : 17,963,560,000 yen (including capital reserves) *Number of employees as of the end of February 2024: 317 (consolidated group) *As of the end of February 2024 Main business: Real estate consulting business (logistics facility development, hotel development, healthcare facility development, overseas business)
More details about this release:
https://prtimes.jp/main/html/rd/p/000000217.000048076.html



%d